title The FDA wants to add a ‘hot’ label to foods to help consumers identify potentially deadly foodborne diseases article title FDA wants ‘hot label’ for foodborne-disease-causing foods to better identify potentially dangerous food sources article title New FDA guidance will allow people to buy and consume dangerous food without having to prove they were infected by the disease, according a new study.
The report comes after the FDA approved the drug baclofen, a drug that reduces the risk of contracting MRSA, which is also known as enteric-coagulant-resistant Staphylococcus aureus, as a treatment for a rare form of MRSA.
It also comes after reports of the drug killing people in the United States.
The National Academy’s report recommends the FDA make it simpler to identify potentially infectious foods and beverages.
The report comes at a time when the FDA has been under fire for the failure to track foodborne illness outbreaks, as well as for its handling of an outbreak in Canada in which more than 500 people died.
“The FDA is considering new guidance for food safety,” the report says.
“The Agency is seeking public comment on the proposed changes, which would enable consumers to more easily identify potentially hazardous foods and beverage and reduce the burden of illness associated with these foodborne outbreaks.
The Agency believes these changes will help to improve public health.”
In its new guidance, the FDA says that a hot label could be added to foods in the U.K., Canada, New Zealand, France, Germany, Austria, and Austria, as long as it is placed on the label.
The agency also says that hot labels could be placed on drinks like tequila and rum.
The FDA’s proposal says that any new food label must also include the following information: “This product is not for human consumption.”
The FDA also wants consumers to be able to buy the product, which includes the food and drink, and use it to buy or eat the food.
“Hot-labeling would also make it possible for consumers to identify the potential danger posed by the product without having the burden or risk of illness to prove it,” the FDA wrote.